XTX Topco’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

XTX Topco’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-180,566	Closed	-$542	–	2500
2023 Q4	$542	Buy	+180,566	New	+$17.9K	﹤0.01%	1506

XTX Topco's RVLP Position: Q1 2024 in Review

XTX Topco sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q1 2024, closing a stake of 180,566 shares — an estimated $542 sold.

XTX Topco first reported a position in RVLP in Q4 2023 and held it in 1 quarter. The position peaked at $542 in Q4 2023. 0 funds tracked by Wall St. Rank hold RVLP as of Q1 2024.

XTX Topco reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q1 2024 after selling out during the quarter.
XTX Topco sold 180,566 RVL Pharmaceuticals plc Ordinary Shares shares in Q1 2024, an estimated $542.
XTX Topco first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2023 and held it in 1 quarter.
XTX Topco's RVL Pharmaceuticals plc Ordinary Shares position peaked at $542 in Q4 2023.
0 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q1 2024.

Based on XTX Topco's 13F filing for Q1 2024, filed 13 May 2024.